Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1924

1.

Primary schwannoma of the diaphragm.

Abraham E, Schwartz G.

Proc (Bayl Univ Med Cent). 2019 Mar 14;32(2):266-267. doi: 10.1080/08998280.2018.1553498. eCollection 2019 Apr.

PMID:
31191150
2.

Left upper lobectomy for a large incidental simple arteriovenous malformation.

Jamil AK, Schwartz GS, Podgaetz E, Mason DP.

Proc (Bayl Univ Med Cent). 2019 Mar 27;32(2):245-246. doi: 10.1080/08998280.2019.1576093. eCollection 2019 Apr.

PMID:
31191141
3.

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.

Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ.

J Clin Apher. 2019 Jun;34(3):171-354. doi: 10.1002/jca.21705.

PMID:
31180581
4.

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.

White HD, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Erglis A, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lopes RD, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Sritara P, Tricoci P, Zeiher AM, Schwartz GG.

Eur Heart J. 2019 May 23. pii: ehz299. doi: 10.1093/eurheartj/ehz299. [Epub ahead of print]

PMID:
31121022
5.

Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.

Steg PG, Szarek M, Bhatt DL, Bittner VA, Brégeault MF, Dalby AJ, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Ostadal P, Parkhomenko A, Pordy R, Roe MT, Tricoci P, Vogel R, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Committees and Investigators.

Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038840. [Epub ahead of print]

PMID:
31117810
6.

Alirocumab after Acute Coronary Syndrome. Reply.

Schwartz GG, Steg PG, Szarek M.

N Engl J Med. 2019 May 23;380(21):2077. doi: 10.1056/NEJMc1902955. No abstract available.

PMID:
31116934
7.

Estimating glomerular filtration rate in youth with obesity and type 2 diabetes: the iCARE study equation.

Dart AB, McGavock J, Sharma A, Chateau D, Schwartz GJ, Blydt-Hansen T.

Pediatr Nephrol. 2019 May 2. doi: 10.1007/s00467-019-04250-6. [Epub ahead of print]

PMID:
31049718
8.

Correction: HIV Viremia and T-cell Activation Differentially Affect the Performance of Glomerular Filtration Rate Equations Based on Creatinine and Cystatin C.

Bhasin B, Lau B, Atta MG, Fine DM, Estrella MM, Schwartz GJ, Lucas GM.

PLoS One. 2019 Apr 16;14(4):e0215630. doi: 10.1371/journal.pone.0215630. eCollection 2019.

9.

Systematic review: associations of calcium intake, vitamin D intake, and physical activity with skeletal outcomes in people with Type 1 diabetes mellitus.

Gil-Díaz MC, Raynor J, O'Brien KO, Schwartz GJ, Weber DR.

Acta Diabetol. 2019 Apr 15. doi: 10.1007/s00592-019-01334-5. [Epub ahead of print]

PMID:
30989378
10.

Recognizing Material Properties from Images.

Schwartz G, Nishino K.

IEEE Trans Pattern Anal Mach Intell. 2019 Mar 27. doi: 10.1109/TPAMI.2019.2907850. [Epub ahead of print]

PMID:
30932831
11.

Patients with Recent Acute Coronary Syndrome and Polyvascular Disease Derive Large Absolute Benefit from Alirocumab: ODYSSEY OUTCOMES Trial.

Jukema JW, Szarek M, Zijlstra LE, de Silva HA, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Karpov Y, Moryusef A, Pordy R, Prieto JC, Roe MT, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

J Am Coll Cardiol. 2019 Mar 12. pii: S0735-1097(19)33921-X. doi: 10.1016/j.jacc.2019.03.013. [Epub ahead of print]

12.

Inhibition of NF-κB-Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma.

Ambrosini G, Do C, Tycko B, Realubit RB, Karan C, Musi E, Carvajal RD, Chua V, Aplin AE, Schwartz GK.

Cancer Res. 2019 May 1;79(9):2415-2425. doi: 10.1158/0008-5472.CAN-18-3177. Epub 2019 Mar 18.

PMID:
30885979
13.

Control of higher-order cladding mode excitation with tailored femtosecond-written long period fiber gratings.

Heck M, Schwartz G, Krämer RG, Richter D, Goebel TA, Matzdorf C, Tünnermann A, Nolte S.

Opt Express. 2019 Feb 18;27(4):4292-4303. doi: 10.1364/OE.27.004292.

PMID:
30876046
14.

Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.

Mani P, Puri R, Schwartz GG, Nissen SE, Shao M, Kastelein JJP, Menon V, Lincoff AM, Nicholls SJ.

JAMA Cardiol. 2019 Mar 6. doi: 10.1001/jamacardio.2019.0179. [Epub ahead of print]

PMID:
30840024
15.

Behavioral Medicine: a retro/prospective view of the field.

Weiss SM, Schwartz GE.

J Behav Med. 2019 Feb;42(1):5-11. doi: 10.1007/s10865-018-9960-5. Epub 2019 Mar 1.

PMID:
30825085
16.

Hemodynamic Response of the Three Macular Capillary Plexuses in Dark Adaptation and Flicker Stimulation Using Optical Coherence Tomography Angiography.

Nesper PL, Lee HE, Fayed AE, Schwartz GW, Yu F, Fawzi AA.

Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):694-703. doi: 10.1167/iovs.18-25478.

17.

Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension.

Mehanna M, Wang Z, Gong Y, McDonough CW, Beitelshees AL, Gums JG, Chapman AB, Schwartz GL, Bailey KR, Johnson JA, Turner ST, Cooper-DeHoff RM.

Am J Hypertens. 2019 Jun 11;32(7):668-675. doi: 10.1093/ajh/hpz022.

PMID:
30753254
18.

Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques.

Petrovic J, Zhou Y, Fasolino M, Goldman N, Schwartz GW, Mumbach MR, Nguyen SC, Rome KS, Sela Y, Zapataro Z, Blacklow SC, Kruhlak MJ, Shi J, Aster JC, Joyce EF, Little SC, Vahedi G, Pear WS, Faryabi RB.

Mol Cell. 2019 Mar 21;73(6):1174-1190.e12. doi: 10.1016/j.molcel.2019.01.006. Epub 2019 Feb 7.

PMID:
30745086
19.

Impact of dissolved organic matter on mercury and methylmercury sorption to activated carbon in soils: implications for remediation.

Schwartz GE, Sanders JP, McBurney AM, Brown SS, Ghosh U, Gilmour CC.

Environ Sci Process Impacts. 2019 Mar 20;21(3):485-496. doi: 10.1039/c8em00469b.

PMID:
30724289
20.

Whole Transcriptome Analysis of Renal Intercalated Cells Predicts Lipopolysaccharide Mediated Inhibition of Retinoid X Receptor alpha Function.

Saxena V, Fitch J, Ketz J, White P, Wetzel A, Chanley MA, Spencer JD, Becknell B, Pierce KR, Arregui SW, Nelson RD, Schwartz GJ, Velazquez V, Walker LA, Chen X, Yan P, Hains DS, Schwaderer AL.

Sci Rep. 2019 Jan 24;9(1):545. doi: 10.1038/s41598-018-36921-z.

21.

Predicting Splicing from Primary Sequence with Deep Learning.

Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, Kosmicki JA, Arbelaez J, Cui W, Schwartz GB, Chow ED, Kanterakis E, Gao H, Kia A, Batzoglou S, Sanders SJ, Farh KK.

Cell. 2019 Jan 24;176(3):535-548.e24. doi: 10.1016/j.cell.2018.12.015. Epub 2019 Jan 17.

PMID:
30661751
22.

New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion.

Farino ZJ, Morgenstern TJ, Maffei A, Quick M, De Solis AJ, Wiriyasermkul P, Freyberg RJ, Aslanoglou D, Sorisio D, Inbar BP, Free RB, Donthamsetti P, Mosharov EV, Kellendonk C, Schwartz GJ, Sibley DR, Schmauss C, Zeltser LM, Moore H, Harris PE, Javitch JA, Freyberg Z.

Mol Psychiatry. 2019 Jan 9. doi: 10.1038/s41380-018-0344-6. [Epub ahead of print]

PMID:
30626912
23.

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma.

Chua V, Orloff M, Teh JL, Sugase T, Liao C, Purwin TJ, Lam BQ, Terai M, Ambrosini G, Carvajal RD, Schwartz G, Sato T, Aplin AE.

EMBO Mol Med. 2019 Feb;11(2). pii: e9081. doi: 10.15252/emmm.201809081.

24.

Sorafenib for Advanced and Refractory Desmoid Tumors.

Gounder MM, Mahoney MR, Van Tine BA, Ravi V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S, Pishvaian MJ, Riedel RF, Sabagh T, Tap WD, Horvat N, Basch E, Schwartz LH, Maki RG, Agaram NP, Lefkowitz RA, Mazaheri Y, Yamashita R, Wright JJ, Dueck AC, Schwartz GK.

N Engl J Med. 2018 Dec 20;379(25):2417-2428. doi: 10.1056/NEJMoa1805052.

PMID:
30575484
25.

Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder.

An JY, Lin K, Zhu L, Werling DM, Dong S, Brand H, Wang HZ, Zhao X, Schwartz GB, Collins RL, Currall BB, Dastmalchi C, Dea J, Duhn C, Gilson MC, Klei L, Liang L, Markenscoff-Papadimitriou E, Pochareddy S, Ahituv N, Buxbaum JD, Coon H, Daly MJ, Kim YS, Marth GT, Neale BM, Quinlan AR, Rubenstein JL, Sestan N, State MW, Willsey AJ, Talkowski ME, Devlin B, Roeder K, Sanders SJ.

Science. 2018 Dec 14;362(6420). pii: eaat6576. doi: 10.1126/science.aat6576.

26.

Modifying emergency department electronic prescribing for outpatient opioid analgesia.

Schwartz GD, Harding AM, Donaldson SR, Greene SL.

Emerg Med Australas. 2019 Jun;31(3):417-422. doi: 10.1111/1742-6723.13192. Epub 2018 Dec 3.

PMID:
30508874
27.

A Self-Regulating Gap Junction Network of Amacrine Cells Controls Nitric Oxide Release in the Retina.

Jacoby J, Nath A, Jessen ZF, Schwartz GW.

Neuron. 2018 Dec 5;100(5):1149-1162.e5. doi: 10.1016/j.neuron.2018.09.047. Epub 2018 Oct 25.

PMID:
30482690
28.

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial.

Szarek M, White HD, Schwartz GG, Alings M, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Kimura T, Kiss RG, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Tricoci P, Xavier D, Zeiher AM, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

J Am Coll Cardiol. 2019 Feb 5;73(4):387-396. doi: 10.1016/j.jacc.2018.10.039. Epub 2018 Nov 11.

29.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
30.

Oleoylethanolamide differentially regulates glycerolipid synthesis and lipoprotein secretion in intestine and liver.

Pan X, Schwartz GJ, Hussain MM.

J Lipid Res. 2018 Dec;59(12):2349-2359. doi: 10.1194/jlr.M089250. Epub 2018 Oct 28.

PMID:
30369486
31.

Iohexol-measured glomerular filtration rate in children and adolescents with chronic kidney disease: a pilot study comparing venous and finger stick methods.

Staples A, Wong C, Schwartz GJ.

Pediatr Nephrol. 2019 Mar;34(3):459-464. doi: 10.1007/s00467-018-4110-4. Epub 2018 Oct 12.

PMID:
30315406
32.

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.

Willeit P, Ridker PM, Nestel PJ, Simes J, Tonkin AM, Pedersen TR, Schwartz GG, Olsson AG, Colhoun HM, Kronenberg F, Drechsler C, Wanner C, Mora S, Lesogor A, Tsimikas S.

Lancet. 2018 Oct 13;392(10155):1311-1320. doi: 10.1016/S0140-6736(18)31652-0. Epub 2018 Oct 4.

PMID:
30293769
33.

The authors reply.

Ng DK, Schwartz GJ, Schneider MF, Furth SL, Warady BA.

Kidney Int. 2018 Oct;94(4):828-829. doi: 10.1016/j.kint.2018.06.016. No abstract available.

PMID:
30243319
34.

Clinical value of plasma renin activity and aldosterone concentration in the evaluation of secondary hypertension, a case of reninoma.

Hommos MS, Schwartz GL.

J Am Soc Hypertens. 2018 Sep;12(9):641-643. doi: 10.1016/j.jash.2018.06.001. Epub 2018 Jun 7. No abstract available.

PMID:
30220304
35.

Targeted therapies for pediatric psoriasis.

Schwartz G, Paller AS.

Semin Cutan Med Surg. 2018 Sep;37(3):167-172. doi: 10.12788/j.sder.2018.048.

PMID:
30215634
36.

Typology and Circuitry of Suppressed-by-Contrast Retinal Ganglion Cells.

Jacoby J, Schwartz GW.

Front Cell Neurosci. 2018 Aug 27;12:269. doi: 10.3389/fncel.2018.00269. eCollection 2018. Review.

37.

Receptive field center-surround interactions mediate context-dependent spatial contrast encoding in the retina.

Turner MH, Schwartz GW, Rieke F.

Elife. 2018 Sep 6;7. pii: e38841. doi: 10.7554/eLife.38841.

38.

Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity.

Iqbal NJ, Lu Z, Liu SM, Schwartz GJ, Chua S Jr, Zhu L.

JCI Insight. 2018 Sep 6;3(17). pii: 123000. doi: 10.1172/jci.insight.123000. eCollection 2018 Sep 6.

39.

Classes of ITD Predict Outcomes in AML Patients Treated with FLT3 Inhibitors.

Schwartz GW, Manning B, Zhou Y, Velu P, Bigdeli A, Astles R, Lehman AW, Morrissette JJD, Perl AE, Li M, Carroll M, Faryabi RB.

Clin Cancer Res. 2019 Jan 15;25(2):573-583. doi: 10.1158/1078-0432.CCR-18-0655. Epub 2018 Sep 4.

PMID:
30181385
40.

Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders.

Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, Tofte S, Dunn JD, Feldman SR, Clark AR, Schwartz G, Eichenfield LF.

Am J Clin Dermatol. 2018 Dec;19(6):821-838. doi: 10.1007/s40257-018-0383-4. Review.

PMID:
30168085
41.

Preclinical Evaluation of Nintedanib, a Triple Angiokinase Inhibitor, in Soft-tissue Sarcoma: Potential Therapeutic Implication for Synovial Sarcoma.

Patwardhan PP, Musi E, Schwartz GK.

Mol Cancer Ther. 2018 Nov;17(11):2329-2340. doi: 10.1158/1535-7163.MCT-18-0319. Epub 2018 Aug 30.

PMID:
30166401
42.

A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.

D'Adamo DR, Dickson MA, Keohan ML, Carvajal RD, Hensley ML, Hirst CM, Ezeoke MO, Ahn L, Qin LX, Antonescu CR, Lefkowitz RA, Maki RG, Schwartz GK, Tap WD.

Oncologist. 2018 Aug 20. pii: theoncologist.2018-0160. doi: 10.1634/theoncologist.2018-0160. [Epub ahead of print]

PMID:
30126857
43.

Preoperative Use of Statins in Carotid Artery Stenting: A Systematic Review and Meta-analysis.

Texakalidis P, Giannopoulos S, Jonnalagadda AK, Chitale RV, Jabbour P, Armstrong EJ, Schwartz GG, Kokkinidis DG.

J Endovasc Ther. 2018 Oct;25(5):624-631. doi: 10.1177/1526602818794030. Epub 2018 Aug 13.

PMID:
30101624
44.

The role of dietary competition in the origination and early diversification of North American euprimates.

Stroik LK, Schwartz GT.

Proc Biol Sci. 2018 Aug 1;285(1884). pii: 20181230. doi: 10.1098/rspb.2018.1230.

PMID:
30068683
45.

Ovarian Cancer Incidence in the U.S. and Toxic Emissions from Pulp and Paper Plants: A Geospatial Analysis.

Hanchette C, Zhang CH, Schwartz GG.

Int J Environ Res Public Health. 2018 Jul 31;15(8). pii: E1619. doi: 10.3390/ijerph15081619.

46.

Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.

Nicholls SJ, Andrews J, Kastelein JJP, Merkely B, Nissen SE, Ray KK, Schwartz GG, Worthley SG, Keyserling C, Dasseux JL, Griffith L, Kim SW, Janssan A, Di Giovanni G, Pisaniello AD, Scherer DJ, Psaltis PJ, Butters J.

JAMA Cardiol. 2018 Sep 1;3(9):815-822. doi: 10.1001/jamacardio.2018.2121.

PMID:
30046828
47.

Ranking Coal Ash Materials for Their Potential to Leach Arsenic and Selenium: Relative Importance of Ash Chemistry and Site Biogeochemistry.

Schwartz GE, Hower JC, Phillips AL, Rivera N, Vengosh A, Hsu-Kim H.

Environ Eng Sci. 2018 Jul 1;35(7):728-738. doi: 10.1089/ees.2017.0347.

48.

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers.

Schwartz GW, Petrovic J, Zhou Y, Faryabi RB.

Front Genet. 2018 Jun 15;9:205. doi: 10.3389/fgene.2018.00205. eCollection 2018.

49.

YouTube Videos as a Source of Information About Clinical Trials: Observational Study.

Hillyer GC, MacLean SA, Beauchemin M, Basch CH, Schmitt KM, Segall L, Kelsen M, Brogan FL, Schwartz GK.

JMIR Cancer. 2018 Jun 26;4(1):e10060. doi: 10.2196/10060.

50.

The dynamic receptive fields of retinal ganglion cells.

Wienbar S, Schwartz GW.

Prog Retin Eye Res. 2018 Nov;67:102-117. doi: 10.1016/j.preteyeres.2018.06.003. Epub 2018 Jun 23. Review.

PMID:
29944919

Supplemental Content

Loading ...
Support Center